Rani Therapeutics Holdings, Inc.
RANI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001856725
In the last 90 days, Rani Therapeutics Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Rani Therapeutics Holdings, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +4 vs. Q1 2022
- Shares held
- 2.83M
- +268.2K (+10.5%) vs. Q1 2022
- Total value
- $29.1M
- −$5.42M (−15.7%) vs. Q1 2022
- New holders
- 4
- 9 more added
- Sold out
- 0
- 6 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RANI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 68 | $34.7M |
| Q1 2026 | 74 | $31.4M |
| Q4 2025 | 64 | $60.5M |
| Q3 2025 | 38 | $2.02M |
| Q2 2025 | 39 | $3.32M |
| Q1 2025 | 38 | $4.58M |
| Q4 2024 | 42 | $5.23M |
| Q3 2024 | 31 | $12.8M |
| Q2 2024 | 34 | $11.8M |
| Q1 2024 | 37 | $10.7M |
| Q4 2023 | 34 | $10.9M |
| Q3 2023 | 34 | $6.96M |
| Q2 2023 | 35 | $13.3M |
| Q1 2023 | 36 | $15.5M |
| Q4 2022 | 34 | $17.6M |
| Q3 2022 | 32 | $30.4M |
| Q2 2022 | 28 | $29.1M |
| Q1 2022 | 24 | $34.5M |
| Q4 2021 | 22 | $20.3M |
| Q3 2021 | 15 | $19.6M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Rani Therapeutics Holdings, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Alphabet Inc. | 714,471 | $7.38M | 0.40% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 493,584 | $5.10M | 3.50% | 00.0% | Unchanged |
| United Services Automobile Association | 481,300 | $4.89M | 0.13% | 00.0% | Unchanged |
| Vanguard Group Inc | 333,129 | $3.44M | 0.00% | +43,022+14.8% | Added |
| BlackRock Inc. | 206,832 | $2.14M | 0.00% | +49,458+31.4% | Added |
| Millennium Management LLC | 111,781 | $1.16M | 0.00% | +79,256+243.7% | Added |
| Alpha Square Group S, LLC | 101,603 | $1.05M | 0.44% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 73,449 | $758.0K | 0.00% | +2,183+3.1% | Added |
| Aspireon Wealth Advisors | 71,811 | $742.0K | 0.33% | +71,811 | New |
| Lasry Marc | 62,828 | $649.0K | 0.99% | 00.0% | Unchanged |
| Stifel Financial Corp | 42,495 | $439.0K | 0.00% | +595+1.4% | Added |
| State Street Corp | 26,142 | $270.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 19,012 | $196.0K | 0.00% | −331−1.7% | Reduced |
| Crossvault Capital Management LLC | 14,285 | $148.0K | 0.06% | +14,285 | New |
| Wells Fargo & Company | 12,530 | $129.0K | 0.00% | +57+0.5% | Added |
| Northern Trust Corp | 11,430 | $118.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 10,739 | $111.0K | 0.00% | −16,081−60.0% | Reduced |
| Islay Capital Management, LLC | 9,611 | $99.0K | 0.10% | +9,611 | New |
| Canton Hathaway, LLC | 8,600 | $89.0K | 0.03% | +8,600 | New |
| The PNC Financial Services Group, Inc. | 7,416 | $77.0K | 0.00% | +7,116+2,372.0% | Added |
| Morgan Stanley | 4,098 | $43.0K | 0.00% | +820+25.0% | Added |
| UBS Group AG | 2,538 | $26.0K | 0.00% | −1,032−28.9% | Reduced |
| Bank of America Corp | 2,145 | $22.0K | 0.00% | −1,010−32.0% | Reduced |
| Tower Research Capital LLC (TRC) | 1,583 | $16.0K | 0.00% | +1,045+194.2% | Added |
| JPMorgan Chase & Co | 1,188 | $12.0K | 0.00% | −1,141−49.0% | Reduced |
| Citigroup Inc | 377 | $4.00K | 0.00% | −45−10.7% | Reduced |
| Daiwa Securities Group Inc. | 58 | $1.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 27 | $0 | 0.00% | 00.0% | Unchanged |